Anti-leukotrienes for asthma
35 results
1 - 35
Anti-leukotrienes for asthma 
Addition of anti‐leukotriene agents to inhaled corticosteroids for chronic asthma- Anti-leukotrienes versus inhaled corticosteroids in the treatment of asthma
- Addition of anti‐leukotriene agents to inhaled corticosteroids in children with persistent asthma
- Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma
- Addition of anti‐leukotriene agents to inhaled corticosteroids for adults and adolescents with persistent asthma
- Anti‐leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
- Addition to inhaled corticosteroids of long‐acting beta2‐agonists versus anti‐leukotrienes for chronic asthma
- Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma
- Leukotriene receptor antagonists for non‐cystic fibrosis bronchiectasis
- Long-term management of asthma
- Diagnosis and treatment of childhood asthma
- Omalizumab for asthma in adults and children: Cochrane systematic review
- Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adults
- Leukotriene receptor antagonists for eczema
- Anti‐interleukin‐13 and anti‐interleukin‐4 agents versus placebo, anti‐interleukin‐5 or anti‐immunoglobulin‐E agents, for people with asthma
- Oral xanthines as maintenance treatment for asthma in children
- Omega‐3 fatty acid supplementation for cystic fibrosis
- Use of medication during pregnancy